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Abstract
Indoleamine-2,3-dioxygenase-1 (hIDO1) has sparked an interest in cancer research
as an immunotherapeutic target. Its structure includes a loop, named the JK-loop,
that controls the orientation of the substrate or the inhibitor within the active site.
However, little has been reported about the crystal structure of that loop. For the
first time, in the present work, the conformation of the JK-loop is determined in the
presence of the heme cofactor in the active site through X-ray diffraction experiments
(2.44 Å). Molecular Dynamics trajectories are also carried out to provide a dynamical
information about the loop according to the presence of cofactor. Such new structural
and dynamical information highlights the importance of the JK-loop in confining the
labile heme cofactor into the active site.
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1. Introduction
Due to its degradation into numerous bioactive metabolites, L-Tryptophan (L-Trp) is
the less abundant but essential amino acid in mammals (Badawy, A., 2017; Nienhaus,
K. et al., 2018; King, N. J. C. et al., 2007). Although the catabolism of L-Tryptophan
occurs along four possible pathways, the main way to transform L-Trp is the kynure-
nine pathway (KP), allowing the transformation of 95% of the L-Tryptophan avail-
able from food (Phillips, R. S. et al., 2019). Through KP, L-Trp is converted into
L-kynurenine to produce essential metabolites such as redox cofactors, neuroprotec-
tors and neurotoxics (Kolodziej, L. R. et al., 2011). As a result, the KP pathway confers
to L-Trp a central role in many diseases, including disruption of the immune response
(Cancer, HIV) and neurological disorders (Alzheimer’s disease, Parkinson’s disease or
Huntington’s disease) (Munn, D. H. et al., 2013; Mellor, A. L. et al., 2017; Phillips,
R. S. et al., 2019). Therefore, enzymes of the kynurenine pathway can be considered
as a set of therapeutic targets.
Human Indolenamine 2,3-dioxygenase-1 (hIDO1) and human Tryptophan 2,3-dioxgenase
(hTDO) are two heme-containing enzymes that are responsible for the initial as well
as the rate-limiting step of the kynurenine pathway (Raven, E. L, 2017). First men-
tioned in 2018 by Nelp et al. (Nelp, M. et al., 2018) and subsequently supported by
Pham et al. (Pham, K. N. et al., 2019), this heme cofactor is labile in hIDO1. Using a
molecule of O2, hIDO or hTDO transforms L-Trp into N-formylkynurenine (NFK) by
an oxidative cleavage of the C2-C3 double bond in the indole moiety (Fig. 1). As hIDO
and hTDO are expressed in human tumors, this reaction step has raised an interest
in the cancer research, particularly in cancer immune escape and in the resistance to
immunotherapy (Uyttenhove, C. et al., 2003; Moon, Y. W. et al., 2015; Takikawa,
O., 2005; Prendergast, G. C. et al., 2018; Hoffmann, D. et al., 2019). The induction of
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hIDO1 is controlled, among others, by interferons (α, β and γ) which induce inflam-
matory signals. Therefore, while hTDO catabolizes excess dietary L-Trp to maintain
metabolites level, hIDO1 regulates immunity by deactivating T cells. Overexpression
of hIDO1 results in local depletion of L-Trp and accumulation of L-kynurenine in the
extracellular compartment, which exerts an immunosuppressive response by decreas-
ing T cells activation (Uyttenhove, C. et al., 2003; Mellor, A. L. et al., 2004; Munn,
D. H. et al., 2007; Katz, J. B. et al., 2008; Prendergast, G. C., 2008; Moon, Y. W.
et al., 2015; Munn, D. H. et al., 2016). Over the years, hIDO1 inhibitors have been
developed and tested in clinical trials (Indoximod, Epacadostat, PF-06844003, Navox-
imod and Linrodostat) (Moon, Y. W. et al., 2015; Prendergast, G. C. et al., 2018).
Nevertheless, the recent failure of Epacadostat in phase III of the clinical trials sug-
gests that inhibition of hIDO1 alone is not sufficient to solve the problem of immune
escape (Prendergast, G. C. et al., 2018; Pham, K. N. et al., 2019; Long, G. V.. et
al., 2019; Peng, Y.-H. et al., 2020) and triggers a revision of the enzyme functioning.
Indeed, it is recognized that there is a lack of information on hIDO1, which is neces-
sary to design new inhibitors.
Fig. 1. First step of the kynurenine pathway. Degradation of L-Tryptophan into N-
formylkynurenine using hIDO or hTDO.
Since the publication of the two first structures of hIDO1 by Sugimoto et al. in
2006 (Sugimoto, H. et al., 2006), many structures of hIDO1 with L-Trp or different
inhibitors have been deposited to the PDB (Tojo, S. et al., 2014; Peng, Y.-H. et
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al., 2016; Wu, Y. et al., 2017; Crosignani, S. et al., 2017; Lewis-Ballester, A. et al.,
2017; Lewis-Ballester, A. et al., 2018; Nelp, M. et al., 2018; Alexandre, J. A. C. et
al., 2018; Luo, S. et al., 2018; Pham, K. N. et al., 2018; Kumar, S. et al., 2019; Zhang,
H. et al., 2019; Pham, K. N. et al., 2019; Rohrig, U. F. et al., 2019; Peng, Y.-H. et
al., 2020; White, C. et al., 2020). Particularly, recent improvements involving surface
mutations allowed the generation of high-resolution structures (from 1.7Å to 2.7 Å)
soaked with L-Trp or inhibitors (Luo, S. et al., 2018). So far, only few articles focus on
an in-depth analysis of structural aspects of hIDO1 (Pham, K. N. et al., 2019; Lewis-
Ballester, A. et al., 2018; Pham, K. N. et al., 2018; Lewis-Ballester, A. et al., 2017;
Sugimoto, H. et al., 2006).
As already mentioned, the JK-loop is very likely involved in the closure of the active
site, so that it plays a key role in the inhibition of the enzyme. However, the loop struc-
ture has not been fully resolved yet, especially its N-terminal part. The C-terminal
part is better resolved and, according to its conformation, the JK-loop structures can
be classified in three categories (Supporting Information, Fig. SI1): a closed conforma-
tion (PDB codes: 6PZ1, 6E46, 6E35, 6CXU, 6CXV, 5WHR, 6F0A, 5WMU, 5WMV,
5WMW, 5WMX), an intermediate conformation (PDB codes: 6E43 (B), 5ETW (A),
5EK2 (B), 5EK3 (B)) and an open conformation (PDB codes: 6E40 (D), 6E41, 6E42
(D), 6E44 (B), 6E45 (B)). Molecular Dynamics simulations carried out by Alvarez and
coworkers also show that the JK-loop is composed of a fixed C-terminal and a more
flexible N-terminal part, and they observe the existence of the three interconvertible
conformations of the C-terminal component (Álvarez, L. et al., 2016). In parallel, the
authors suggest that the N-terminal part may play a role in protein-protein interac-
tion or in post-translational modifications, and highlight its possible role in immune
regulation of hIDO1 by regulating its activity.
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In the present study, we experimentally determine structural properties of hIDO1
using a ferrous hIDO1 crystal structure at a medium resolution level (2.44 Å). The
structure consists of a heme-linked hIDO1 enzyme with a complete JK-loop. Coupled
with Molecular Dynamics simulations, the present work provides information on the
JK-loop conformation, but also on its dynamics as a function of the presence of the
cofactor heme. Such information is essential for a better understanding of the catalytic
and inhibition mechanisms for this drug target.
2. Material and methods
2.1. Expression, purification and crystallisation
The human IDO1 gene was expressed using a plasmid pET-28a provided by Tong et
al. (Luo, S. et al., 2018). The plasmid, containing the His-tagged protein with two sur-
face mutations (K116A, K117A), was transformed into Escherichia coli BL21(DE3)
cells. The cells were grown in a lysogeny broth (LB) medium supplemented with
50 µg/mL of kanamycin at 37 ◦C until the culture reaches an optical density of
0.6 at 600 nm. The induction occurs by addition of 0.4 mM of isopropyl-β-D-1-
thiogalactopyranoside and 0.75 mM of 5-aminolevulinic acid during 20 hours at 18
◦C. Cells were harvested by centrifugation at 4500 rpm for 30 min. Pellets were resus-
pended in lysis buffer (50 mM Tris base/HCl pH 8.0, 500 mM NaCl, 20 mM imidazole,
5% (v/v) glycerol) supplemented with protease-inhibitor cocktails (cOmplete EDTA-
free, one tablet per 50 ml of solution from Roche) and lysed by sonication on ice.
Cellular debris were removed by centrifugation at 12 500 rpm for 1 hour. The lysate
was filtered on 0.2 mm filter (Whatman, GE Healthcare) and purified by immobi-
lized metal affinity chromatography (IMAC) using an HisTrap FF Crude column (GE
Healthcare). After washing of the flow through with buffer A (50 mM Tris base/HCl
pH 8.0, 500 mM NaCl, 20 mM imidazole, 5% (v/v) glycerol), the elution occurs using
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a gradient of 30 min (0% to 100%) in buffer B (50 mM Tris base/HCl pH 8.0, 500 mM
NaCl, 500 mM imidazole, 5% (v/v) glycerol). Reddish fractions containing pure hIDO1
were collected. The purity was followed by 12% SDS-PAGE stained using Coomassie
Blue.
2.2. Crystallization assay
After exchanged into a crystallization buffer containing 5mM of HEPES/NaOH pH
7.6, 200 mM NaCl and 5 mM DTT, the protein was concentrated using amicon with
a 10 kDa molecular-weight cutoff membrane to reach a concentration of 16 mg/ml.
Crystallization assays were carried out with the hanging-drop vapor-diffusion method
at 293 K. The wells contained a solution made of 14% of polyethylene glycol 3350 and
0.1M in KH2PO4/NaOH at a pH of 6.25. Drops were made with 1 µL of the well
solution and 1 µL of the protein solution. Red crystals appeared within one day. Before
data collection, crystals were soaked for 2 min with the well solution supplemented
with a cryo-solution at a final concentration of 20% of glycerol and 20 mM of sodium
dithionite. Sodium dithionite allowed the reduction of the heme iron into the ferrous
state. Subsequently, the crystals were flash-cooled in liquid nitrogen.
2.3. X-ray data collection and model refinement
The diffraction data were collected at 100 K at the PROXIMA-1 beamline of
the SOLEIL synchrotron (Gif-sur-Yvette, France) using PIXEL detector (DECTRIC
EIGER X 16M), at the single wavelength of 0.979 Å for 3600 pictures. The data pro-
cessing was achieved with the XDS program (Kabsch, W., 2010). The structure was
solved by molecular replacement performed by Phaser (McCoy, A. J. et al., 2007) with
a monomer from the PDB entry 6e43 as the model (Luo, S. et al., 2018). The model
building and structure refinement were performed using Coot (Emsley, P. et al., 2010)
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and PHENIX (Adams, P. D. et al., 2010) under NCS restraint on torsion-angles.
Anisotropy in the data was removed using the extension Morph model on Phenix
(Terwilliger, T.C., 2012). The heme cofactor was added to the monomers using Elbow
(Moriarty, N.W. et al., 2009). Data collection and refinement statistics are summarized
in Table 1. The cavity volumes in the active site were calculated using the POCASA
1.1 server with a grid of 1 Å and a probe radius of 1.0 Å using the chain C of the
crystal structure. For visualization purposes, all Figures were generated using PyMOL
(Schrödinger, LLC, 2010).
2.4. Molecular Dynamics
Molecular Dynamics (MD) simulations of the apo-form of hIDO1 and hIDO1 bound
to the heme cofactor were run using the program GROMACS 5.1.4. (Abraham, M. J.
et al., 2016) with the CHARMM27 force field (FF) (MacKerell Jr, A. D. et al., 2000)
and the CMAP corrections for the protein. The monomer C of the crystal structure
(PDB entry: 7A42) was used as starting model. For the simulation without the heme
cofactor, the construction of the model was performed by removing the heme group
of the chain C of the crystal structure. A RMSD analysis between the chain and
the monomers of the apo-forms reported in the PDB yields values of 0.3 Å for the
structure 6E43, 0.5 Å for 6AZV, and 0.6 Å for 6AZW. These RMSD values are low
enough to consider the unbound chain C of 7A62 as a model of the apo-form of the
enzyme. H atoms were added using GROMACS. To reduce the calculation time, the
systems were solvated using all-atom TIP3P and coarse-grained SIRAH water particles
(Darré et al., 2012; Gonzalez, H.C.et al., 2013; Leonardo et al., 2015). A cubic box
was built around the protein with at least 2.0 nm between the box and the protein
atoms. TIP3P water molecules were placed in a shell of 1.0 nm thickness around the
molecular system. Then, the space between the shell and the box was completed with
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coarse-grained SIRAH water particles. The use of a hybrid all-atom/coarse grained
water solvent allows to model a protein system which remains fully surrounded by
all-atom water molecules as illustrated in Supporting information, Fig. SI2. Finally,
the total charge of the system was neutralized with sodium ions randomly placed in
the bulk of the SIRAH water particles.
The optimization and MD trajectories were generated under the particle mesh
Ewald (PME) periodic boundary conditions (PBC). A cut-off value of 1.2 nm was
applied for Coulomb and Van der Waals interactions. Temperature and pressure were
fixed using the Parrrinello-Rahman (Parrinello, M., et al., 1981) and V-Rescale algo-
rithms (Bussi, G. et al., 2007), respectively. Covalent bonds involving hydrogen atoms
were constrained using the LINCS algorithm (Hess, B. et al., 1997). The resulting
system was optimized using the steepest descent algorithm for a maximal number of
2500 steps and an initial step size of 0.05 nm. During the equilibration stage of the
system, the temperature was progressively increased from 50 K to 310 K using short
MD runs. The first run consisted of a 10 ps simulation at 50 K on the system obtained
after optimization. Afterwards, the system was relaxed for two runs of 20 ps at 150
K and 310 K. Finally, a run of 50 ps at 310 K and 1 bar was performed to finalize
the relaxation of the system. The equilibration was extended during 60 ns with a time
step of 2 fs at 310 K and 1 bar. The production step was ran for 200 ns (100 × 106
steps) with a time step of 2 fs. The evolution of the system during the equilibration
and the production stages was followed using energy and RMSD (Root mean square
displacement) profiles. The calculation of the RMSD and RMSF (Root mean square
fluctuation) profiles were achieved using the initially optimized protein structure as
the reference structure, which presents an RMSD of 0.2 Å in comparison to the crystal
structure.
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3. Results and discussion
3.1. Overall structure
The hIDO1 crystals obtained with the vapor-hanging-drop method belong to the
P21212 space group, and the unit cell parameters are a=80.96 Å, b=117.95 Å and
c=216.41 Å. The heme-bound hIDO1 crystal structure is composed of four monomers
(A, B, C, D) with missing atoms at the extremities. More precisely, in monomer A,
the protein is refined from the amino acid S12 to K401, while in monomers B and
C the structure includes the amino acid G11 to G403. Finally, in monomer D, the
amino acids G11 to K401 are refined. The residues that are located at the N-terminal
extremity of the JK-loops, i.e., from P362 to T379 in A and D, and from P362 to
G378 in B, are not refined. Contrarily, the JK-loop of monomer C is fully resolved,
leading to a complete structure of the loop ever reported. The superposition of the
four monomers gives the following RMSD between A-B (0.123 Å), A-C (0.239 Å), A-D
(0.226 Å), B-C (0.236 Å), B-D (0.216 Å), and D-C (0.139 Å). The mean RMSD value
between each monomer of the crystal structure and their corresponding monomer from
the literature gives a value of 0.29 ± 0.012 Å (PDB entry : 6e45 (Luo, S. et al., 2018)).
In the structure, each monomer is composed of two domains, i.e., the small domain
considered as the N-terminal moiety and the large domain consisting in a bundle of 13
α-helices (Fig. 2, (a)). The largest domain includes the catalytic core formed by the
heme cofactor and the α-helices B and D, this latter being part of the DE-fragment
which closes the active site together with the JK-loop (Q360 to G380). Indeed, the DE-
fragment is composed of the α-helix D (N222 to V229), the DE-loop (L230 to S263)
and two 310-helices (N240 to S244 and S263 to V269). In this general organization,
an additional 310-helix built from R296 to M299 occurs in the monomers A and B.
Pre-α-helix D, and the BC- and HI-loops are involved in dimerization in the crystal
structure. A parallel β-sheet comprised between V102-L103 and V248-Y249 in the DE-
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fragment binds both domains (black circle, Fig. 2, (b)). The small domain contains
the residues G11 to D158. It is made of six α-helices (involving amino acids Y36 to
H45, H45 to S52, Q54 to K61, D72 to G93, P104 to E119, and V125 to V130, or helix
A, contributing to the active site), four 310-helices (S12 to H16, P33 to F35, S66 to
L70, and T144 to E146), and a small anti-parallel β-sheet formed by the amino acids
K135-K136 and M148-D149 (Fig. 2, (b)).
Fig. 2. (a) Crystal structure of monomer C. Small and large domains are in green and
grey, respectively. In the large domain, the pre-helix D, BC-loop, and HI-loop, are
coloured in blue. The DE-fragment is in magenta, and the JK-loop is represented in
light pink. (b) Lateral view of the small domain showing the helices P104 to E119
and Y36 to H45. A β-sheet links the small and the large domain (black oval).
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3.2. Quality of the refined structure
The heme-bound hIDO1 structure is solved at a resolution of 2.44 Å, with Rwork
and Rfree equal to 0.2118 and 0.2579 respectively. Seven glycerol molecules and two
chloride ions are also present in the structure. The Ramachandran plot, obtained using
MolProbility (Chen et al., 2010), shows that 96 % of the residues adopt allowed Φ-Ψ
values, and only 0.33 % are reported as outliers in the structure. Rotamers outliers
amount to 1.3 %. Since most of these outliers are located in the JK-loop, their con-
formation variability highlights a greater flexibility. Statistics for the refined model
(bond lengths and bond angles RMSD values) stress a good quality of the structure.
The crystal structure has an overall B-factor of 39.83 Å2. Particularly, residues Q360
to G380 are characterized by the largest B values in each monomer (Fig. 3). It reflects
the enhanced dynamics of the protein residues around the JK-loop.
Fig. 3. B-factor (Å2) profile of the residues main chain for each monomer.
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Table 1. Data collection and refinement statistics for crystal structure. Values in parentheses
are for the highest resolution shell.
PDB code 7A62
Data collection
Beamline SOLEIL - PROXIMA-1
Wavelength (Å) 0.979
Resolution (Å) 49.18-2.438 (2.525-2.438)
Space group P21212
a, b, c (Å) 80.96 117.95 216.41
α , β, γ (◦) 90 90 90
Total reflections 1067214 (93823)





I/σ (l) 8.81 (0.84)
Completeness (%) 84.0 (98.0)
Multiplicity 13.7 (12.4)
Wilson B-factor (Å2) 38.98
Refinement
No. of reflections 65724 (4878)
















Bond lengths (Å) 0.014





Rotamers outliers (%) 1.3
Clash score 6.46
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3.3. Description of the dimerization interface
While hIDO1 functions as a monomer in the biological state, the hIDO1 unit cell
of the crystal structure contains four molecules per asymmetric unit. On the whole,
the four hIDO1 molecules of an asymmetric unit are interconnected and can be con-
sidered as a dimer of dimers. Translation and inversion operations appear between
the dimers A/D and B/C. Alignment of the two dimers results in a RMSD of 0.26
Å. Such a crystal packing results in multiple monomer/monomer interfaces in both
the small and large domains of the protein. In the small domain, mutations such as
K116A and K117A allow the alignment of α-helix P104-E119 of monomer A with the
same helix of monomer D of a contiguous asymmetric unit, and inversely (Fig. 4, (a)).
Similar interface occurs between monomers B and C. The A/D (D/A) and B/C (C/B)
dimers involve hydrophobic effect triggered by an apolar cluster containing residues
V109, F252 and W253 in one monomer, and A116 and A117 in the partner monomer
(magenta boxes in Fig. 4, (a)). Electrostatic interactions also occur between residues
E119/K257, with distance values of 3.6 Å (green boxes in Fig. 4, (a)). In addition, both
residues Q113 of a dimer interact with each other through weak hydrogen bonds (the
acceptor-donor distances range from 3.6 Å to 3.9 Å). The helix S66 to L70 strength-
ens the dimerization through electrostatic interactions between D68 of one monomer
and R109 in the other monomer (distance is equal to 3.9 Å). Chalcogens interactions
are also observed between the electrophilic sulfur atoms of M64 and the nucleophilic
carboxylate oxygen atoms of D68 (distance values between 3.6 Å and 3.9 Å) (orange
boxes in Fig. 4, (a)) (Iwaoka, M. et al., 2015; Pal, D. et al., 2001). Selected distances
are provided in Supporting information (Table SI1). The small domain also contains
a second dimerization site that is located in the neighborhood of the α-helix Y36 to
H45 and Q54 to K61 (Fig. 4, (b)). Helix Y36 to H45 and residue R58 of monomer
A and B dimerize with α-helix Q54 to K61 of monomer D and C, respectively. The
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stabilization occurs using hydrogen bonds (acceptor-donor distances between 2.1 Å
and 3.6 Å), electrostatic interactions involving R58, E57 and K61 (bond-lengths dis-
tances between 2.2 Å and 4.2 Å), a π-cation interaction between F41 and R58 from
the next asymmetric unit (distance value of 3.9 Å, angle of 70.5 degrees with respect
to aromatic cycle) strengthened by a displaced parallel π-π interaction between F41
and H45 (distance of 4.3Å between the two centroids).
Fig. 4. Small domain dimerization interface between the monomer A of the reference
crystal structure (gray) and the monomer D of the surrounding asymmetric unit
(gold). The amino acids of the crystal structure involved in the dimerization are
in blue. The labels of the residues of monomer D are underlined. Hydrogen bonds,
electrostatic, and chalcogen interactions are shown with black, orange, and red
dotted lines, respectively. (a) Global view and zooms of the dimerization interface
containing the α-helix P104-E119 and the fragment S66 to L70. (b) Dimerization
interface with α-helix Y36 to H45, R58 and α-helix Q54 to K61.
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The large domain of the enzyme presents three dimerization sites involving the
pre-α-helix D, BC-loop, and HI-loop. All of the distances calculated between the
monomers are listed in the Supporting Information (Table SI2). The pre-α-helix allows
the dimerization of monomers A/D and B/C inside a single asymmetric unit (Fig. 5,
(a)). Monomer/monomer interactions by ions pair, already described in other proteins
(Birktoft, J. J., 1983; Shankar, B. G. et al., 2007), appear between H218 of A and D219
of D, with distance values between 3.4 Å and 4.9 Å. Hydrogen bonds involving water
molecules strengthen the interface and are characterized by distances between 2.2 Å
and 3.8 Å. The BC-loop and HI-loop of monomer A and B interact with the equivalent
loop of the monomers C and D from a contiguous asymmetric unit respectively (Fig.
5, (b)). These interactions (A/C, B/D, C/A and D/B) are conducted through ions
pair and hydrogen bonds networks. In particular, strong electrostatic bonds involve
R193 and D325 of both monomers (distance between 2.5 Å and 4.7 Å). Interactions
between Q191 and K323 also participate to the asymmetric unit organization.
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Fig. 5. Large domain dimerization interface between the monomer A of the refer-
ence crystal structure (gray) and the monomer of the surrounding asymmetric unit
(gold). The amino acid of the crystal structure involved in the dimerization are in
blue. The labels of the residues of monomer of the surrounding asymmetric unit
are underlined. Hydrogen bonds, electrostatic, and ion-pair interactions are shown
with black, orange, and blue dotted lines, respectively. (a) Dimerization interface
A/D within a single asymmetric unit involving the pre-α-helix D. (d) Dimerization
interface between A/C involving the BC- and HI-loops.
The structures from Luo et al. (PDB codes 6E40, 6E41, 6E42, 6E44, 6E45 and
6E46 (Luo, S. et al., 2018)) are the most similar ones to our structure, as far as the
crystal organization is concerned. Nevertheless, slight differences exist in the sym-
metry operations between the monomers of the asymmetric unit, leading to a high
RMSD. In the literature, hIDO1 is reported to be a monomeric enzyme. However, the
analysis of different crystal packings allows a sampling of possible conformations. In
the crystal structures, dimeric interfaces stabilize the JK-loop, the C-terminal part
being involved in more interactions than the N-terminal part of the loop. These inter-
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faces involve the J- and K- α-helices, the H45-S52 α-helix (Supporting information,
Fig. SI3, (a)), and the Q54-K61 α-helix (Supporting information, Fig. SI3, (b)) from
the next asymmetric unit. Weak interactions contribute to the organization of the
N-terminal part of the loop, in particular hydrogen bonds involving Q348/R58, T351,
and water molecules, as well as close contacts between F41/S359 and L49/I356. In
contrast, amino acids of the K α-helix are involved in strong electrostatic interac-
tions (D48/K389, E51/E392, E51/K397, R56/E401 and K94/E396) and contribute to
a dense hydrogen bond network (S52/R392/K94/water and R56/E401/water), and a
chalcogen interaction between D48 and M385. Resulting from these interfaces, the C-
terminal part of JK-loop is more stable leading to better refinement of this extremity
in contrast to the N-terminal part that remains unclear. In the present crystal struc-
ture, an empty space is generated through the crystal packing close to the JK-loop
allowing a less constrained conformation (Supporting information, Fig. SI4). Never-
theless, in the same way as observed for the C-terminal extremity in other structures
of hIDO1, the stabilization of the pre-α-helix D close to the N-terminal part of the
JK-loop facilitates the refinement of this part of the loop. Differences in crystal pack-
ings thus allow the observation of distinct structural features on the protein surface. It
highlights the importance of analyzing polymorphism during protein refinement and
justifies the study of alternative crystal forms to provide a more detailed structural
picture of a protein.
3.4. Conformation of JK-loop
In the crystal structure reported here, a fully refined JK-loop is obtained for the
monomer C. It allows a better understanding of the enzyme structure. Quality of
the electron density for that region of the protein is still poor but all heavy atoms
of the main chain of the JK-loop could be traced and refined for the first time. The
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N-terminal end of the loop (residues Q360-L374) is still very flexible, as confirmed
by high B factors (Fig. 6, (a)) and the electron density distribution remains unclear
for some lateral chains and for residue S372. However, overall, the electron density
distribution for most of the main chain of the loop is defined. Most residues of the C-
terminal part of the JK-loop (E375-G380) are defined (Fig. 6, (a) and (b)) except for
A376. The refined JK-loop adopts a conformation between the intermediate and the
fully extended ones. The C-terminal part of the loop interacts with the heme moiety
through electrostatic interactions with K377 (Fig. 6, (b)) at 4.3 Å and 5.1 Å between
the residue and the carboxylate of the cofactor. Compared to what is observed in
other available crystal structures, the conformation of the JK-loop presented here is
new although close to the one reported by Luo et al. (6E41, 6E42, 6E44 and 6E45)
(Luo, S. et al., 2018). In the present crystal structure, the JK-loop completes the α-
helix K with a supplementary turn. This conformation of the JK-loop prevents the
orientation of T379 and G380 into the active site, while residue K377 interacts with the
heme cofactor. Consequently, the C-terminal part is oriented towards the active site,
in an opposite way to the opened conformations of Luo et al. Because of this overall
conformation, the pocket A is not open in the crystal structure due to a movement of
residues 262-265, as there is no ligand. The same can be observed in other published
IDO1 X-ray structures. The pocket B is formed within the free space between the
DE-fragment and the JK-loop (Fig. 6, (c)) and allows the entrance of a L-Trp into
the enzyme (volume of 249 Å3, as calculated with POCASA 1.1 server) (Yu, J. et
al., 2010) (Supporting information, Fig. SI5). As previously mentioned, the JK-loop
may play a role in the regulation of the enzyme activity. Indeed, the conformation of
this loop may help the protein to regulate the entrance of L-Trp into the active site
and thus its degradation, while maintaining the heme moiety inside the active site
through interactions with residue K377.
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Fig. 6. Conformation of the JK-loop in crystal structure. The 2Fo-Fc map around the
residues is represented at 0.5 σ (blue mesh), only density of interest in drawn for
clarity. (a) Density around N-terminal part (residues Q360 to L374) represented in
two levels: amino acid from Q360 to S368 in orange and amino acid from S368 to
L374 in blue. (b) Density around the JK-loop in the C-terminal part. Interaction
of K377 with the carboxylate function of heme moiety in orange. (c) Pocket B
resulting in the active site.
3.5. Link between JK-loop conformation and heme lability supported by Molecular
Dynamics
While Alvarez and coworkers (Álvarez, L. et al., 2016) studied the dynamics of the
whole protein in presence of L-Trp, the MD calculations reported here focus on the
JK-loop conformation changes in the presence or in the absence of the heme cofactor.
In order to investigate the dependence of the JK-loop conformation on the heme group,
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MD simulations were performed with and without the cofactor. In the simulation with
the cofactor, this latter remains free to move in order to be consistent with its reported
lability (Nelp, M. et al., 2018; Pham, K. N. et al., 2019). During production stage,
simulations illustrate the independence of the C-terminal extremity of the JK-loop in
relation to the N-terminal extremity. The simulated conformations present only slight
difference at the level of the C-terminal part of the loop with the cofactor compared to
the crystallographic structure (Fig. 7, (b) and Supporting information, Fig. SI6, (b)).
The differences between the simulations without the cofactor and the crystallographic
structure are more significant (Fig. 7, (b) and Supporting information, Fig. SI6, (b)).
Contrarily, the N-terminal part adopts two totally different conformations during the
MD simulations (Fig. 8, (a) and Supporting information, Fig. SI6, (c)). The RMSD
and RMSF analyses (Fig. 7, (a), (b) and (c)) confirm that the JK-loop has a significant
dynamical character as recorded in experimental structures.
The conformation of the C-terminal part of the loop (considered between E375
and G380) is linked to the presence of the heme cofactor. In presence of the heme
cofactor, lysine K377 is oriented towards the active site. The average distance between
K377 and the carboxylate of the heme cofactor amounts to 6.8 Å ± 2.4 Å and 6.9
Å ± 2.4 Å. To characterize the JK-loop opening as a function of the presence of the
cofactor, the distance between K377 and A264, located above the heme moiety, is
chosen as a criterion. In the simulated structure with the heme cofactor, the mean
distance between the atoms CB of A264 and NZ of K377 amounts to 12.5 Å ± 2.3
Å. The standard deviation highlights a variability in the location of the lysine K377
(Supporting Information, Fig. SI7). In comparison to previous results reported in the
literature by Alvarez and coworkers (Álvarez, L. et al., 2016), the most recurrent
conformation of the JK-loop in the C-terminal extremity can be considered as an
intermediate conformation (Fig. 7, (d)). In the absence of the heme cofactor, K377
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is oriented towards the solvent with the amine group pointing towards the outside of
the enzyme. Without the heme moiety, the distance between the atoms CB of A264
and NZ of K377 considerably increases to 25.5 Å ± 1.3 Å (Fig. 7, (d)). Thus, this
displacement of K377 is seen as a stage that initiates the opening of the JK-loop.
Fig. 7. Impact of the heme cofactor on the JK-loop conformation (with the cofactor
(cyan), without the cofactor (green)). RMSD (a) and RMSF analysis (b) of the JK-
loop according to the cofactor occupancy. (c) RMSD of the C-terminal part of the
JK-loop according to the cofactor occupancy (d) Conformation of the JK-loop on
the C-terminal part according to the presence of the heme cofactor. Opening of the
JK-loop illustrate with the heme (left) and without the heme (right) as obtained
from 200 ns of MD simulation at 300 K and 1 bar.
Regarding the N-terminal part (Q360-L374), the MD simulations support the high
flexibility of this part of the loop as illustrated by the larger RMSD values (Fig. 8,
(a)). Conformational differences are detected between the crystallographic structure
and the MD structures (Supporting information, Fig. SI6, (c)). In the presence of
the heme cofactor, the conformation of the N-terminal part is close to α-helix D,
leading to a more compact protein. (Fig. 8, (c)) Hydrogen bonds (1.3 ± 1.0) are
established between the two fragments (Fig. 8, (b)). Consequently to this compact
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conformation, few hydrogen bonds are observed between the N-terminal fragment and
the solvent (45.5 ± 4.8). Contrarily, in the simulated apo-enzyme, the loop extends
from the enzyme into the solvent (Fig. 8, (c)). Thus, few hydrogen bonds (0.7 ± 0.9)
are observed between the N-terminal extremity and the DE-fragment (Fig. 8, (b)) but
more hydrogen bonds are established between the solvent and this part of the JK-loop
(55.5 ± 4.2). Conformation variability of the N-terminal extremity may be essential
for the protein. With this simultaneous opening of the C-terminal and the N-terminal
extremities in absence of the cofactor, the protein pocket B is open and allows a free
heme cofactor to enter in the active site. Consequently, the N-terminal part of the loop
regulates hIDO1 activity. Similar hypothesis is consistent with the heme lability and
the incorporation of a L-Trp in the inhibitor site in absence of the heme cofactor. At
last, independently from the presence or the absence of the cofactor, the N-terminal
extremity involves the folding of residues E369 to E375 into a short helix stabilized
by an increased number of hydrogen bonds (Fig. 8, (d)). This folding (Fig. 8, (d))
indicates the possible structural organization of the segment despite its flexibility.
IUCr macros version 2.1.10: 2016/01/28
23
Fig. 8. Impact of the heme cofactor on the JK-loop conformation on the N-terminal
part (with the cofactor (cyan), without the cofactor (green), DE-fragment is
coloured in orange). (a) RMSD analysis of the N-terminal part (Q360-L374) of
the JK-loop according to the cofactor occupancy. (b) Hydrogen bonds pairs (cut-
off value of 3.5 Å and 30 degrees) analyses for residues Q360 to L374, per frame of
20 ps. (c) Conformation of N-terminal extremity according to the presence of heme
cofactor with frontal view (left) and lateral view (right) as obtained from 200 ns of
MD simulation at 300 K and 1 bar. (d) Conformation of helix between S369 to E375
(red) in simulation with heme cofactor as obtained from 200 ns of MD simulation
at 300 K and 1 bar.
4. Conclusion
The hIDO1 crystal structure reported here contains four monomers in the asymmet-
ric unit. For the first time, a complete refined JK-loop was determined in one of
the monomers. The hIDO1 structure was refined at a resolution of 2.44 Å and the
Rwork and Rfree are equal to 0.2118 and 0.2579, respectively with reasonable statis-
tics (Ramachandran plot, rotamer analysis and r.m.s deviation values). The structure,
which is mainly composed of two domains consisting of α and 310 helices, is involved in
multiple dimerization interfaces between the monomers within the asymmetric unit.
The refined conformation of the JK-loop adopts a new conformation between the
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reported intermediate and the fully extended ones. Lysine K377, located at the C-
terminal part of the loop, is involved in an electrostatic interaction with the heme
cofactor. The N-terminal part of the loop is very flexible, this segment being associated
with high B-factors values. As a result of the intermediate conformation of the loop,
the active site of the enzyme forms a ”pocket B” with a volume of 249 Å3. In the
absence of a ligand, the JK-loop intermediate conformation of hIDO1, is seen to plays
a crucial role in the regulation of the activity on the enzyme and/or the stable binding
of the heme cofactor into the active site.
Through the analysis of Molecular Dynamic (MD) trajectories, the flexibility of the
JK-loop was quantified by Root Mean Square Displacement (RMSD) and Root Mean
Square Fluctuation (RMSF) profile analyses. Simulation with a potentially labile heme
cofactor leads to a structure consistent with the crystal structure, the heme remaining
stabilized by interactions with lysine K377. The simulated lack of a heme cofactor
induces (1) an opening of the C-terminal extremity of the JK-loop, starting at K377
as indicated by the increase by a factor of 2 of the distance between A264 and K377
(2) a transfer of hydrogen bonds from the DE-fragment to the solvent molecules at
the level of the N-terminal extremity. Regarding the N-terminal part of the JK-loop,
a helix-type folding of residues E369 to E375, stabilised by an increased number of
hydrogen bonds is observed, independently from the presence or the absence of the
cofactor.
In conclusion, the experimental and MD results presented in the paper complete the
data previously reported in literature on hIDO1 while stressing on the importance of
the JK-loop conformation. This new combined information shows the importance of
the JK-loop on the protein dynamics that occurs during catalysis and the importance
of the conformation of the JK-loop in the absence of an other ligand to maintain a
labile heme into the active site. The crucial role that the labile heme cofactor plays
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and that was confirmed here deserves further biophysical studies that will benefit from
the structural work disclosed in the present study.
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Synopsis
This article consists of a in-deep analysis of structural aspects for the heme-bound structure
of hIDO1 with a complete refined JK-loop (overall crystal structure, quality of the structure,
dimerization interfaces, and analysis of the JK-loop conformation) followed by a Molecular
Dynamics study of the influence of the heme occupation on the JK-loop conformation.
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Influence of the presence of the heme cofactor on the
JK-loop structure in indoleamine-2,3-dioxygenase-1:
Supporting information
1. Type of conformation for JK-loop in the C-terminal part from
literature
Fig. SI1. Conformation of the C-terminal part for the JK-loop in the literature. (a)
Closed conformation from 5WHR (green) (b) Intermediate conformation from 5EK3
(blue) (c) Open conformation from 6E40 (orange).
2. Solvatation in Molecular Dynamic simulation
Fig. SI2. All-atom water solvent in each simulation. (a) Simulation with the heme
cofactor. (b) Simulation without the heme cofactor.
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3. Dimerization interface
Table SI1. Distances involved in dimeric interaction in the small unit from Fig. 4.
Dimerisation Monomer Amino acids Monomer Amino acids Distances
interface (atoms) (atoms) (Å)
P104-E119 A D68 (OD2) D M64 (SD) 3.9
A M64 (SD) D D68 (OD1) 3.8
A M64 (SD) D D68 (OD2) 3.6
A D68 (OD2) D R105 (NH2) 3.9
A Q113 (NE2) D Q113 (OE1) 3.8
A Q113 (OE1) D Q113 (NE2) 3.9
A K257 (NZ) D E119 (OE1) 3.6
A K257 (NZ) D E119 (OE2) 3.6
Y36-H45 A N37 (OD1) D R58 (NH2) 2.6
and Q54-K61 A D38 (OD1) D W609 (O) 2.7
D W609 (O) D R58 (NH2) 3.6
D W609 (O) D Q54 (OE1) 2.3
D W608 (O) D R58 (NH1) 2.3
D W608 (O) D E57 (OE2) 2.9
D R58 (NH1) D E57 (OE2) 4.2
A R58 (NH1) D E57 (OE1) 2.9
A R58 (NH1) D E57 (OE2) 3.4
A R58 (NH2) D E57 (OE1) 2.3
A R58 (NH2) D E57 (OE2) 3.5
D E57 (OE1) D K61 (NZ) 3.0
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Table SI2. Distance involved in dimeric interaction in the large unit from Fig. 5.
Dimerization Monomer Amino acids Monomer Amino acids Distances
interface (atoms) (atoms) (Å)
Helix D A D219 (OD1) A W613 (O) 2.4
A D219 (OD1) A W745 (O) 3.7
A D219 (OD2) A W745 (O) 3.8
A D219 (OD1) A W735 (O) 2.4
A W745 (O) D W735 (O) 3.4
A W745 (O) D W718 (O) 2.2
D W718 (O) D H220 (O) 3.6
A D219 (OD2) D W621 (O) 3.5
D W612 (O) D W718 (O) 3.6
A W612 (O) D H218 (O) 2.4
A W612 (O) D E146 (OE2) 3.2
A W612 (O) D H220 (NE2) 3.2
D W614 (O) D E146 (OE1) 2.4
D W614 (O) D E146 (OE2) 2.6
D W614 (O) D W732 (O) 2.4
D W614 (O) D W603 (O) 2.5
D W603 (O) D H220 (NE2) 3.8
A H218 (NE2) D D219 (OD1) 3.8
A H218 (ND1) D D219 (OD2) 4.0
A H218 (ND1) D D219 (OD1) 4.1
A H218 (NE2) D D219 (OD2) 4.9
BC-loop A R193 (NH1) A D325 (OD1) 2.8
and HI-loop A R193 (NH1) A D325 (OD2) 3.3
A R193 (NE) A D325 (OD2) 2.7
A D325 (OD2) C R193 (NE) 4.7
A Q191 (OE1) C K323 (NZ) 4.1
A K323 (NZ) C Q191 (OE1) 4.3
C K323 (NZ) C Q191 (OE1) 4.1
C D325 (OD2) C R193 (NH1) 3.4
C D325 (OD1) C R193 (NH1) 2.9
C D325 (OD2) C R193 (NE) 2.7
IUCr macros version 2.1.10: 2016/01/28
4
Fig. SI3. Dimerization interfaces in 5WHR around the JK-loop. (a) Interface with the
α-helix H45-S52 (b) Interface with the α-helix Q54-K61.
Fig. SI4. Dimerization interface of the α-helix D (in blue) in relation to the JK-loop
(in pink).
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4. Conformation of JK-loop in 7A62
Fig. SI5. Volume of the pocket B resulting of the JK-loop conformation. Cavity was
generated by POCASA 1.1. server (Yu, J. et al., 2010).
5. Link between JK-loop conformation and heme lability supported by
Molecular Dynamics
Fig. SI6. Superimposition of the crystal (pink), MD simulation with the heme cofactor
at t = 200 ns (cyan), and MD simulation structure without the heme cofactor at
t = 200 ns (green) (a) Overall view (b) C-terminal part of the JK-loop (E375 to
G380) (c) N-terminal part of the JK-loop (Q360 to E374).
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Fig. SI7. Superimposition of different locations for K377 obtained from the MD simu-
lation with the heme cofactor. Conformations are clustered in three groups: closed
(in orange, the distance between K377 and A264 varies from 6 Å to 10 Å, 16.1%
of the conformations), intermediate (in cyan, the distance between K377 and A264
varies from 10 Å to 16 Å, 79.3% of the conformations) and open (in red, the dis-
tance between K377 and A264 is larger than 16 Å, 4.6% of the conformations).
Percentages were calculated over a 200 ns MD simulation at 300 K and 1 bar.
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